Javascript must be enabled to continue!
Changes in Gait Characteristics of Stroke Patients with Foot Drop after the Combination Treatment of Foot Drop Stimulator and Moving Treadmill Training
View through CrossRef
Objective. To study the changes in gait characteristics of stroke patients with foot drop after the combination treatment of foot drop stimulator and moving treadmill training and thus provide a basis for the improvement in a foot drop gait after stroke. Methods. Sixty patients with hemiplegia and foot drop caused by stroke were randomly divided into two groups of 30: the test group and the control group. Both groups received basic rehabilitation training. On this basis, the test group received the combination treatment of foot drop stimulator and moving treadmill training. The control group received foot drop stimulator training. Both groups received consecutive treatment for 3 weeks, five times a week, and every single time lasted for 30 minutes. Before and after the treatment, a gait watch three-dimensional gait analysis system was used to measure and record the maximum angles of flexion of the affected side’s hip, knee, and ankle; the pace; the step length asymmetry; the iEMG of the tibialis anterior muscle; the functional ambulation category; and Ashworth’s modified spasticity classification of the gastrocnemius. Results. After treatment, in the two groups, the maximum angles of flexion of the affected side’s hip, knee, and ankle improved, the pace increased, the step length asymmetry decreased, the iEMG of the tibialis anterior muscle increased, the functional ambulation category improved, and Ashworth’s modified spasticity classification of the gastrocnemius decreased, but the above changes in the test group were better than those in the control group. The difference is statistically significant (
p
<
0.05
). Conclusions. The combination treatment of the foot drop stimulator and moving treadmill can significantly improve stroke patients’ foot gait and promote the normalization of hip flexion, knee flexion, and ankle flexion. It can increase the pace, significantly reduce the step length asymmetry, reduce the muscle tone of the gastrocnemius, and improve walking function.
Title: Changes in Gait Characteristics of Stroke Patients with Foot Drop after the Combination Treatment of Foot Drop Stimulator and Moving Treadmill Training
Description:
Objective.
To study the changes in gait characteristics of stroke patients with foot drop after the combination treatment of foot drop stimulator and moving treadmill training and thus provide a basis for the improvement in a foot drop gait after stroke.
Methods.
Sixty patients with hemiplegia and foot drop caused by stroke were randomly divided into two groups of 30: the test group and the control group.
Both groups received basic rehabilitation training.
On this basis, the test group received the combination treatment of foot drop stimulator and moving treadmill training.
The control group received foot drop stimulator training.
Both groups received consecutive treatment for 3 weeks, five times a week, and every single time lasted for 30 minutes.
Before and after the treatment, a gait watch three-dimensional gait analysis system was used to measure and record the maximum angles of flexion of the affected side’s hip, knee, and ankle; the pace; the step length asymmetry; the iEMG of the tibialis anterior muscle; the functional ambulation category; and Ashworth’s modified spasticity classification of the gastrocnemius.
Results.
After treatment, in the two groups, the maximum angles of flexion of the affected side’s hip, knee, and ankle improved, the pace increased, the step length asymmetry decreased, the iEMG of the tibialis anterior muscle increased, the functional ambulation category improved, and Ashworth’s modified spasticity classification of the gastrocnemius decreased, but the above changes in the test group were better than those in the control group.
The difference is statistically significant (
p
<
0.
05
).
Conclusions.
The combination treatment of the foot drop stimulator and moving treadmill can significantly improve stroke patients’ foot gait and promote the normalization of hip flexion, knee flexion, and ankle flexion.
It can increase the pace, significantly reduce the step length asymmetry, reduce the muscle tone of the gastrocnemius, and improve walking function.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Treadmill Versus Overground Gait Training in Patients with Lower Limb Burn Injury: A Comparative Study
Treadmill Versus Overground Gait Training in Patients with Lower Limb Burn Injury: A Comparative Study
Abstract
The primary goal of the rehabilitation services offered to patients with lower limb burns is to enhance gait function. Exercise on a treadmill and conventio...
Gait Training Techniques in Children
Gait Training Techniques in Children
The development of gait is a fundamental milestone in childhood that signifies the onset of functional independence, social engagement, and cognitive exploration. The book “Gait Tr...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Gait assessments in patients with early Parkinson's disease
Gait assessments in patients with early Parkinson's disease
Introduction : Gait disturbances are affected in all stages of PD. At the early stages of the disease, gait disturbances can be present but in most patients, it does not cause sign...
Acute Exercise and Oxidative Stress: CrossFit™ vs. Treadmill Bout
Acute Exercise and Oxidative Stress: CrossFit™ vs. Treadmill Bout
Abstract
CrossFit™, a popular high-intensity training modality, has been the subject of scrutiny, with concerns of elevated risk of injury and health. Despite these ...

